NOBELPHARMA CO., LTD.

ACTIVE

1-12-30, HONCHO, AOBA-KU, Sendai, Miyagi, Japanwww.nobelpharma.co.jpHolding251–500 employeesEstablished: 2003-01-01

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

15.0%

Trial Status Distribution

Active, not recruiting

30.0%

Completed

30.0%

Recruiting

25.0%

Clinical Trials

Trials sponsored by this organization (20)

A Phase 3 study of NPC-06 in Patients With Pain Associated with acute Herpes Zoster

Active, not recruiting

interventional

Sep 202250 participants

Placebo-controlled comparative study of NPC-12Y oily gel in patients with skin lesions associated with tuberous sclerosis complex

Active, not recruiting

interventional

Jul 202240 participants

Phase I/II study of NPC-22

Active, not recruiting

interventional

Mar 202215 participants

A noninferiority study of NPC-25 in patients with hypozincemia

Completed

interventional

Jan 2022190 participants

Page 1 of 3

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations

NOBELPHARMA CO., LTD.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (20)

Phase I clinical trial of NPC-33 and NPC-26sc to High-Risk Neuroblastoma

A Phase III study of NPC-25 in pediatric patients with hypozincemia

A phase II/III study of NPC-22

A pharmacokinetic study of NPC-15 Tablet (for adult use)

A Phase 3 study of NPC-06 in Patients With Pain Associated with acute Herpes Zoster

Placebo-controlled comparative study of NPC-12Y oily gel in patients with skin lesions associated with tuberous sclerosis complex

Phase I/II study of NPC-22

A noninferiority study of NPC-25 in patients with hypozincemia

Approvals

Approvals by Agency

Recent Approvals

News